|
|
|
|
¡¡ |
|
¡¡ |
|
|
|
¡¡ |
HOME > ÇÐȸ°£Ç๰ >
¿ë¾î»çÀü |
|
Á¦¸ñ |
ÇѼ¾º´ Áø´ÜÀ» À§ÇÑ ´ÙÁß »ý¹°ÁöÇ¥¸¦ ÀÌ¿ëÇÑ Á¢±Ù |
|
|
|
|
ÀúÀÚ |
±èÁ¾ÇÊ, ¹ÚÁøÈ£, ±èÀ±Áö, ¹ÚÁø¸ð |
¼Ò¼Ó |
Çѱ¹ÇѼ¾º¹ÁöÇùȸ ¿¬±¸¿ø |
|
|
³âµµ |
2020 |
±Ç |
53 |
|
|
È£ |
1 |
¹øÈ£ |
1 |
|
|
½ÃÀÛÆäÀÌÁö |
3 |
³¡ÆäÀÌÁö |
14 |
|
|
÷ºÎ |
ÇѼ¾º´ Áø´ÜÀ» À§ÇÑ ´ÙÁß »ý¹°ÁöÇ¥¸¦ ÀÌ¿ëÇÑ Á¢±Ù.pdf |
|
|
¿ä¾à |
We confirmed that using integrated analysis of three biomarkers is more significant than the single indicator in the diagnosis of leprosy. In addition, the use of multiple biomarkers is thought to contribute to the management of leprosy in the community.
▪ key words: Biomarker, C-reactive protein, Diagnosis, Interferon gamma induced protein 10, Leprosy, Phenolic glycolipid 1 |
|
|
³»¿ë |
|
| |
¡¡ |
|
|
|
|
|
|
|
|